Free tool
Stocks far below their 52-week high
We cover 7 companies trading at least 50% below their own 52-week high. The median market value in the group is $32.08B. Across the group, the median move over the past trading day is +0.09%. Price change over the past year runs from −54.4% to −45.5% across the middle 80 percent of the group, with a median of −49.5%.
Other lists in this group
Table
7 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% | Oct 28, 2026 |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% | Oct 28, 2026 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% | Oct 29, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% | Nov 3, 2026 |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% | Oct 19, 2026 |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% | Oct 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.